Literature DB >> 23105292

Spectrum of monoclonal gammapathies in Andhra Pradesh.

T Malati1, B Yadagiri, D M Krishna, V Shantaram, D Raghunadharao, K Subbarao.   

Abstract

In the present study, monoclonal gammapathy was identified in a total of 245 patients of plasma cell dyscrasias during period of 1987 to 2000. The monoclonal band was identified in serum by agar gel electrophoresis in all the cases and in urine in a few cases. Characterization of paraprotein (monoclonal immunoglobulin class and light chain type) was carried out by employing immunoelectrophoresis and/or immunofixation electrophoresis using heavy chain specific gamma, alpha, mu, delta and epsilon and light chain specific kappa (K), lambda (λ) antisera. Serum immunoglobulins Ig G, Ig A, and Ig M were estimated by immunoturbidometry. Serum urea, creatinine, uric acid, alkaline phosphatase, total proteins, albumin, calcium and phosphorus were estimated by using routine biochemical methods. Among the 245 cases, 73.1% monoclonal gammapathies were of secretory type and 7.3% were non-secretory. Monoclonal gammapathies were associated with 80.4% of multiple myeloma, 8.9% of solitary plasmacytoma, 4.1% of extra-medullary plasmacytoma, 3.3% of lymphoma and 2.9% of plasma cell leukemia. Classification of secretory monoclonal immunoglobulin revealed monoclonal immunoglobulin Ig G in 74%, Ig A 15% and Ig M in 2.9% cases.

Entities:  

Keywords:  Monoclonal gammapathies; Monoclonal immunoglobulins; Multiple Myeloma; Praproteins

Year:  2001        PMID: 23105292      PMCID: PMC3453618          DOI: 10.1007/BF02867568

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  31 in total

1.  Myelomatosis.

Authors:  J INNES; J NEWALL
Journal:  Lancet       Date:  1961-02-04       Impact factor: 79.321

Review 2.  Monoclonal gammopathies--their identification and biological significance.

Authors:  C K Osterland
Journal:  Clin Chim Acta       Date:  1989-03-15       Impact factor: 3.786

3.  Occurrence of monoclonal components in general practice: clinical implications.

Authors:  F Aguzzi; M R Bergami; C Gasparro; V Bellotti; G Merlini
Journal:  Eur J Haematol       Date:  1992-04       Impact factor: 2.997

Review 4.  Amyloidosis and plasma cell dyscrasias of the musculoskeletal system.

Authors:  K Subbarao; H G Jacobson
Journal:  Semin Roentgenol       Date:  1986-04       Impact factor: 0.800

5.  Pseudohyperphosphataemia in multiple myeloma.

Authors:  E V McCloskey; J Galloway; M A Morgan; J A Kanis
Journal:  BMJ       Date:  1989-12-02

6.  Adult Fanconi syndrome, amyloidosis and marked kappa-light chain proteinuria.

Authors:  P N Finkel; K Kronenberg; A J Pesce; V E Pollak; C L Pirani
Journal:  Nephron       Date:  1973       Impact factor: 2.847

7.  Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management.

Authors:  M Martinez-Maldonado; J Yium; W N Suki; G Eknoyan
Journal:  J Chronic Dis       Date:  1971-07

Review 8.  Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature.

Authors:  J P Fermand; J C Brouet; F Danon; M Seligmann
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

9.  Interpretation of serum calcium in patients with abnormal serum proteins.

Authors:  R B Payne; A J Little; R B Williams; J R Milner
Journal:  Br Med J       Date:  1973-12-15

10.  Diphosphonates and phosphate homoeostasis in man.

Authors:  E V McCloskey; A J Yates; R E Gray; N A Hamdy; J Galloway; J A Kanis
Journal:  Clin Sci (Lond)       Date:  1988-06       Impact factor: 6.124

View more
  1 in total

1.  Tumour markers: An overview.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2007-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.